Aytu Biopharma

AYTU · NASDAQ

$2.01+$0.02 (+1.01%)TodayMarket closed · Oct 21, 4:22 AM ET

Prev close $1.99

About AYTU

Aytu Biopharma, Inc. is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. The company is headquartered in Denver, Colorado and currently employs 82 full-time employees. The company went IPO on 2017-10-20. Its business is focused on the launch of EXXUA and its prescription pharmaceutical products sold primarily through third-party wholesalers and pharmacies and which primarily consists of two product portfolios. Its Attention Deficit Hyperactivity Disorder (ADHD) portfolio consists of Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) , Cotempla XR-ODT, and METADATE CD, which are CNS stimulants indicated for the treatment of ADHD in patients. Its Pediatric portfolio consists of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine indicated to treat various allergic conditions including seasonal and perennial allergic rhinitis, vasomotor rhinitis, Poly-Vi-Flor, and Tri-Vi-Flor. EXXUA is indicated to treat depressive disorder (MDD) in adults.

Employees: 82
Headquarters: Denver, Colorado
Listed: Oct 20, 2017
Sector: Health Care
Industry: Pharmaceuticals
Website: aytubio.com

Leadership

Aytu Biopharma executives
Name	Title	Since	Age
John Donofrio	—	—	58
Joshua Disbrow	—	2015	50
Ryan Selhorn	—	—	44
Jarrett Disbrow	—	2015	50
Greg Pyszczymuka	—	—	46
Carl Dockery	—	—	62
Abhinav Jian	—	—	35
Vivian Liu	—	—	64

Revenue by product and region

Fiscal year ended Jun 30, 2025: $66.38M total revenue

By product

ADHD Portfolio [Member]$57.58M86.7%
The Pediatric Portfolio [Member]$8.77M13.2%
Product and Service, Other [Member]$37.00K0.1%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Aytu Biopharma suppliers and customers
Company	Relationship	Country	Correlation
Reckitt Benckiser Group RKT.L	Supplier and customer	GB	0.15
Merck MRK.DE	Supplier and customer	DE	-0.19
Apollo Med Innovations LLC	Supplier	US	—
Cedars-Sinai Medical Care Foundation	Supplier and customer	US	—
Magna Pharmaceuticals, Inc.	Supplier and customer	US	—
Tris Pharma, Inc.	Supplier and customer	US	—

Similar companies

Companies in the same industry as Aytu Biopharma

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.